The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Placental Transforming Growth Factor-β Is a Downstream Mediator of the Growth Arrest and Apoptotic Response of Tumor Cells to DNA Damage and p53 Overexpression
Open accessAbstract
The p53 tumor suppressor gene and members of the transforming growth factor-beta (TGF-beta) superfamily play central roles in signaling cell cycle arrest and apoptosis (programmed cell death) in normal development and differentiation, as well as in carcinogenesis. Here we describe a distantly related member of the TGF-beta superfamily, designated placental TGF-beta (PTGF-beta), that is up-regulated in response to both p53-dependent and -independent apoptotic signaling events arising from DNA damage in human breast cancer cells. PTGF-beta is normally expressed in placenta and at lower levels in kidney, lung, pancreas, and muscle but could not be detected in any tumor cell line studied. The PTGF-beta promoter is activated by p53 and contains two p53 binding site motifs. Functional studies demonstrated that one of these p53 binding sites is essential for p53-mediated PTGF-beta promoter induction and specifically binds recombinant p53 in gel mobility shift assays. PTGF-beta overexpression from a recombinant adenoviral vector (AdPTGF-beta) led to an 80% reduction in MDA-MB-468 breast cancer cell viability and a 50-60% reduction in other human breast cancer cell lines studied, including MCF-7 cells, which are resistant to growth inhibition by recombinant wild-type p53. Like p53, PTGF-beta overexpression was seen to induce both G(1) cell cycle arrest and apoptosis in breast tumor cells. These results provide the first evidence for a direct functional link between p53 and the TGF-beta superfamily and implicate PTGF-beta as an important intercellular mediator of p53 function and the cytostatic effects of radiation and chemotherapeutic cancer agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Physiological levels of circulating GDF15 are low in healthy humans but increase in disease states and during pregnancy [203] (Table 1).”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [203]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K. N., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,913
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
TGF-β signalling from cell membrane to nucleus through SMAD proteins
Heldin, C., Miyazono, K., & ten Dijke, P. (1997) · Nature · doi:10.1038/37284 · Cited by 3,697
The Transforming Growth Factor-Beta Family
Massagué, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,041
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,911
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K. R., Signer, S. H., Davidson, N. E., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,730
Flagged first, then by citations
Research works printed but not linked: 16
- Weichselbaum, 1992, Semin. Oncol., 19, 14
- Miyashita, 1994, Oncogene, 9, 1799
- Fuchs, 1997, Cancer Res., 57, 2550
- Yount, 1999, Cancer Res., 59, 1362
- Brown, 1999, Cancer Res., 59, 1391
- Peled, 1996, Cancer Res., 56, 2148
- Hoodless, 1998, Curr. Topics Microbiol. Immunol., 228, 235
- Chen, 1988, BioTechniques, 6, 632
- Liebermann, 1995, Oncogene, 11, 199
- Nishizaki, 1999, Clin. Cancer Res., 5, 1015
- Meyers, 1993, Mol. Cell. Biol., 13, 6336
- Hahm, 1994, Mol. Cell. Biol., 14, 7111
- Katayose, 1995, Clin. Cancer Res., 1, 889
- Massague, 1996, Cancer Surv., 27, 41
- Schutte, 1996, Cancer Res., 56, 2527
- Frank, 1998, Clin. Cancer Res., 4, 2521
Cited by
Sorted by citations
Items 101–200 of 254
Yamaguchi, K., Lee, S., Eling, T. E., & Baek, S. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0528 · Cited by 65
Lee, S. E., Kang, S., Choi, M. J., Jung, S.-B., Ryu, M. J., Chung, H. K., Chang, J. Y., Kim, Y. K., Lee, J. H., Kim, K. S., et al. (2017) · Diabetes · doi:10.2337/db17-0333 · Cited by 65
Kim, J., Baek, S. J., Sali, T. M., & Eling, T. E. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0201 · Cited by 64
Brown, D. A., Hance, K. W., Rogers, C. J., Sansbury, L. B., Albert, P. S., Murphy, G. A., Laiyemo, A. O., Wang, Z., Cross, A. J., Schatzkin, A. G., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0786 · Cited by 64
Overview of growth differentiation factor 15 (GDF15) in metabolic diseases
Li, J., Hu, X., Xie, Z., Li, J., Huang, C. L., & Huang, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116809 · Cited by 72
Stone, A., Valdés-Mora, F., Gee, J., Farrow, L., Mcclelland, R., Fiegl, H., Dutkowski, C., McCloy, R., Sutherland, R., Musgrove, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040466 · Cited by 60
Wakchoure, S., Swain, T. M., Hentunen, T. A., Bauskin, A. R., Brown, D. A., Breit, S. N., Vuopala, K. S., Harris, K. W., & Selander, K. S. (2009) · The Prostate · doi:10.1002/pros.20913 · Cited by 65
Soto‐Cerrato, V., Viñals, F., Lambert, J. R., Kelly, J. A., & Pérez‐Tomás, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0266 · Cited by 62
Li, Y.-L., Chang, J., Lee, L., Fan, K., Li, Y., Li, Y., Chiang, C.-H., You, G.-R., Chen, H.-Y., & Cheng, A. (2016) · Oncotarget · doi:10.18632/oncotarget.13649 · Cited by 62
Agarwal, M. K., Hastak, K., Jackson, M. W., Breit, S. N., Stark, G. R., & Agarwal, M. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607210103 · Cited by 62
Graichen, R., Liu, D., Sun, Y., Lee, K., & Lobie, P. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109931200 · Cited by 61
Chen, R., Nagarajan, S., Prince, G. M., Maheshwari, U., Terstappen, L. W. M. M., Kaplan, D. R., Gerson, S. L., Albert, J. M., Dunn, D. E., Lazarus, H. M., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8328 · Cited by 61
Jin, Y., Lee, J.-H., Kim, Y.-M., Oh, G. T., & Lee, H. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.03.014 · Cited by 59
Qian, Y., Jung, Y.-S., & Chen, X. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203185109 · Cited by 59
Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases
Ji, X., Zhao, L., Ji, K., Zhao, Y., Li, W., Zhang, R., Hou, Y., Lu, J., & Yan, C. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0283-7 · Cited by 58
Microarray analysis uncovers retinoid targets in human bronchial epithelial cells
Ma, Y., Koza‐Taylor, P., DiMattia, D. A., Hames, L. M., Fu, H., Dragnev, K. H., Turi, T., BEEBE, J. S., Freemantle, S. J., & Dmitrovsky, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206728 · Cited by 58
Watson, L. M., Chan, A. K. C., Berry, L. R., Li, J., Sood, S. K., Dickhout, J. G., Xu, L., Werstuck, G. H., Bajzar, L., Klamut, H. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301006200 · Cited by 57
Self-citationMartinez, J. M., Sali, T. M., Okazaki, R., Anna, C. H., Hollingshead, M. G., Hose, C. D., Monks, A. P., Walker, N. J., Baek, S. J., & Eling, T. E. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.100081 · Cited by 56
Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis
Zimmers, T. A., Jin, X., Gutierrez, J. C., Acosta, C., McKillop, I. H., Pierce, R. H., & Koniaris, L. G. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0336-4 · Cited by 54
Thomas, R., True, L. D., Lange, P. H., & Vessella, R. L. (2001) · International Journal of Cancer · doi:10.1002/ijc.1291 · Cited by 54
Newman, D. R., Sakaue, M., Koo, J. S., Kim, K. S., Baek, S. J., Eling, T. E., & Jetten, A. M. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.557 · Cited by 54
Karczewska‐Kupczewska, M., Kowalska, I., Nikołajuk, A., Adamska, A., Otziomek, E., Górska, M., & Strączkowski, M. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04139.x · Cited by 56
GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma
Schiegnitz, E., Kämmerer, P. W., Koch, F. P., Krüger, M., Berres, M., & Al‐Nawas, B. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.01.020 · Cited by 53
Growth differentiation factor 15 as a potential therapeutic for treating obesity
Hale, C., & Véniant, M. M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101117 · Cited by 54
Monks, A. P., Harris, E. D., Hose, C. D., Connelly, J., & Sausville, E. A. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.766 · Cited by 53
Macrophage Inhibitory Cytokine-1 Regulates Melanoma Vascular Development
Huh, S. J., Chung, C.-Y., Sharma, A. K., & Robertson, G. P. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090963 · Cited by 53
Chintharlapalli, S. R., Papineni, S., & Safe, S. H. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0002 · Cited by 53
Shin, S. Y., Kim, J. H., Lee, J. H., Lim, Y., & Lee, Y. H. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100651 · Cited by 50
Fairlie, W. D., Zhang, H., Wu, W. M., Pankhurst, S., Bauskin, A. R., Russell, P. K., Brown, P. K., & Breit, S. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010000200 · Cited by 48
Zanier, R., Briot, D., du Villard, J.-A. D., Sarasin, A. R., & Rosselli, F. (2004) · Oncogene · doi:10.1038/sj.onc.1207677 · Cited by 48
GDF-15 in Pulmonary and Critical Care Medicine
Verhamme, F. M., Freeman, C. M., Brusselle, G., Bracke, K. R., & Curtis, J. L. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0379tr · Cited by 47
Soto‐Cerrato, V., Viñals, F., Lambert, J. R., & Pérez‐Tomás, R. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.016 · Cited by 46
CRP Stimulates GDF15 Expression in Endothelial Cells through p53
Kim, Y., Hooten, N. N., & Evans, M. K. (2018) · Mediators of Inflammation · doi:10.1155/2018/8278039 · Cited by 47
Wang, X., Jiang, X., Yu, X., Wang, L., He, S., Feng, F., Guo, L., Jiang, W. B., & Lu, S. (2013) · Cancer Science · doi:10.1111/cas.12331 · Cited by 46
Wollmann, W., Goodman, M. L., Bhat‐Nakshatri, P., Kishimoto, H., Goulet, R. J., Mehrotra, S., Morimiya, A., Badve, S., & Nakshatri, H. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi031 · Cited by 45
Yang, H. S., Choi, H. J., Park, S. H., Kim, J. S., & Moon, Y. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.012 · Cited by 43
Li, J., Xiong, J., Yang, B., Zhou, Q., Wu, Y., Luo, H., Zhou, H., Liu, N., Li, Y., Song, Z., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13406 · Cited by 44
Skipworth, R. J. E., Deans, D. A. C., Tan, B. H. L., Sangster, K., Paterson‐Brown, S., Brown, D. A., Hunter, M., Breit, S. N., Ross, J. A., & Fearon, K. C. H. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605532 · Cited by 44
Kang, S. U., Lee, B., Lee, S., Baek, S. J., Shin, Y. S., & Kim, C. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.07.003 · Cited by 42
Jiang, J., Thalamuthu, A., Ho, J. E., Mahajan, A., Ek, W. E., Brown, D. A., Breit, S. N., Wang, T. J., Gyllensten, U. B., Chen, M., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00097 · Cited by 44
GDF-15: a novel serum marker for metastases in uveal melanoma patients
Suesskind, D., Schatz, A., Schnichels, S., Coupland, S. E., Lake, S. L., Wissinger, B., Bartz‐Schmidt, K. U., & Henke‐Fahle, S. (2011) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1786-6 · Cited by 42
COX inhibitors directly alter gene expression: role in cancer prevention?
Wang, X., Baek, S. J., & Eling, T. E. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9301-4 · Cited by 41
Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma.
Chen, W., & Hu, G. (2015) · PubMed Central · doi:10.7497/j.issn.2095-3941.2014.0015 · Cited by 44
Park, Y.-J., Lee, H., & Lee, J. (2010) · BMB Reports · doi:10.5483/bmbrep.2010.43.2.091 · Cited by 41
Kelly, J. A., Lucia, M. S., & Lambert, J. R. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.11.013 · Cited by 43
Mitochondrial stress and GDF15 in the pathophysiology of sepsis
Fujita, Y., Ito, M., & Ohsawa, I. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108668 · Cited by 42
Upregulation and secretion of macrophage inhibitory cytokine-1 (MIC-1) in gastric cancers
Baek, K. E., Yoon, S. R., Kim, J., Kim, K. S., Kang, S. H., Yang, Y. D., Lim, J., Choi, I., Nam, M. S., Yoon, M., et al. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.12.008 · Cited by 41
Lu, X., He, X., Su, J., Wang, J., Liu, X., Xu, K., De, W., Zhang, E., Guo, R., & Shi, Y. E. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.05.016 · Cited by 39
Wang, X., Yang, X., Sun, K., Chen, J., Song, X., Wang, H., Liu, Z., Wang, C.-X., Zhang, C., & Hui, R. (2009) · Clinical Science · doi:10.1042/cs20080637 · Cited by 39
Emerging roles of growth differentiation factor‑15 in brain disorders (Review)
Jiang, W., Zhang, Z., He, P., Jiang, L., Chen, J.-Z., Zhang, X.-T., Hu, M., Zhang, Y.-K., & Ouyang, X.-P. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10705 · Cited by 40
Ichikawa, T., Suenaga, Y., Koda, T., Ozaki, T., & Nakagawara, A. (2007) · Oncogene · doi:10.1038/sj.onc.1210658 · Cited by 38
Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women
Song, M., Mehta, R. S., Wu, K., Fuchs, C. S., Ogino, S., Giovannucci, E. L., & Chan, A. T. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0307 · Cited by 37
Okamoto, M., Koma, Y., Kodama, T., Nishio, M., Shigeoka, M., & Yokozaki, H. (2020) · Pathobiology · doi:10.1159/000504394 · Cited by 38
Li, S., Wang, Y., Cao, B., Wu, Y., Ji, L., Li, Y.-X., Li, Y., Zhao, Y., Qiao, J., Wang, H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1598 · Cited by 37
Yamaguchi, K., Liggett, J. L., Kim, N.-C., & Baek, S. J. (2006) · Oncology Reports · doi:10.3892/or.15.1.275 · Cited by 37
Whitson, R. J., Lucia, M. S., & Lambert, J. R. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24484 · Cited by 37
Okazaki, R., Moon, Y., Norimura, T., & Eling, T. E. (2006) · Radiation Research · doi:10.1667/rr3492.1 · Cited by 35
Strelau, J., Schmeer, C., Peterziel, H., Sackmann, T., Herold‐Mende, C. C., Steiner, H. H., Weller, M., & Unsicker, K. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.042 · Cited by 35
Jones, M. F., Li, X. L., Subramanian, M., Shabalina, S. A., Hara, T., Zhu, Y. J., Huang, J. L., Yang, Y., Wakefield, L. M., Prasanth, K. V., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.9 · Cited by 34
Cheng, J., Chang, H., & Leung, P. C. K. (2011) · Endocrinology · doi:10.1210/en.2011-0059 · Cited by 34
Chang, J. W., Kang, S. U., Choi, J. W., Shin, Y. S., Baek, S. J., Lee, S., & Kim, C. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.818 · Cited by 32
The Role of Growth Differentiation Factor 15 in Energy Metabolism
Chang, J. Y., Hong, H. J., Kang, S., Kim, J. T., Zhang, B. Y., & Shong, M. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0087 · Cited by 32
Tesei, A., Zoli, W., Fabbri, F., Leonetti, C., Rosetti, M., Bolla, M., Amadori, D., & Silvestrini, R. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.007 · Cited by 32
Xue, H., Fu, Z., Chen, Y., Xing, Y., Liu, J., Zhu, H., & Zhou, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046534 · Cited by 32
A Novel Role for the Coxsackie Adenovirus Receptor in Mediating Tumor Formation by Lung Cancer Cells
Qin, M., Escuadro, B., Dohadwala, M., Sharma, S. P., & Batra, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1490 · Cited by 31
Ünal, B., Alan, S., Başsorgun, C. İ., Karakaş, A. A., Elpek, G. Ö., & Çiftçioǧlu, M. A. (2015) · Archives of Dermatological Research · doi:10.1007/s00403-015-1546-2 · Cited by 30
GDF15 promotes epithelial-to-mesenchymal transition in colorectal
Zhang, Y., Wang, X., Zhang, M., Zhang, Z., Jiang, L., & Li, L. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1466146 · Cited by 30
Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype
Muniyan, S., Pothuraju, R., Seshacharyulu, P., & Batra, S. K. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215664 · Cited by 31
Schiegnitz, E., Kämmerer, P. W., Rode, K., Schorn, T. F., Brieger, J., & Al‐Nawas, B. (2015) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12323 · Cited by 30
El‐Aziz, S. H. A., Endo, Y., Miyamaori, H., Takino, T., & Sato, H. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00547.x · Cited by 30
Wang, L., Liu, Y., Li, W., & Song, Z. (2017) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.12.009 · Cited by 29
CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer
Han, M., Dai, D., Yousafzai, N. A., Wang, F., Wang, H., Zhou, Q., Lu, H., Xu, W., Feng, L., Jin, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21581 · Cited by 29
Yokozaki, H., Koma, Y., Shigeoka, M., & Nishio, M. (2018) · Pathology International · doi:10.1111/pin.12674 · Cited by 29
Feng, H., Chen, L., Wang, Q., Shen, B., Liu, L., Zheng, P., Xu, S., Liu, X., Chen, J., & Teng, J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.403 · Cited by 29
Macrophage Inhibitory Cytokine-1: A review of its pleiotropic actions in cancer
Khaled, Y. S., Elkord, E., & Ammori, B. J. (2012) · Cancer Biomarkers · doi:10.3233/cbm-2012-00287 · Cited by 30
Human astrocytes express 14-3-3 sigma in response to oxidative and DNA-damaging stresses
Satoh, J., Tabunoki, H., Nanri, Y., Arima, K., & Yamamura, T. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.05.007 · Cited by 28
Yin, T., Cho, S.-J., & Chen, X. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.480186 · Cited by 28
Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanism
Shim, M., & Eling, T. E. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0470 · Cited by 27
Keelan, J. A. (2003) · Molecular Human Reproduction · doi:10.1093/molehr/gag068 · Cited by 27
Li, H., Dakour, J., Guilbert, L. J., Winkler‐Lowen, B., Lyall, F., & Morrish, D. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0808 · Cited by 26
The Role of NAG-1/GDF15 in the Inhibition of Intestinal Polyps in APC/Min Mice by Sulindac
Wang, X., Kingsley, P. J., Marnett, L. J., & Eling, T. E. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0196 · Cited by 26
Expression and clinical role of growth differentiation factor-15 in ovarian carcinoma effusions.
Bock, A. J., Stavnes, H. T., Kempf, T., Tropé, C. G., Berner, A., Davidson, B., & Staff, A. C. (2010) · PubMed · doi:10.1111/igc.0b013e3181f7d6be · Cited by 25
Chen, S., Chang, C., Chen, T.-H., Chang, Y.-W., & Lin, S. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.08.015 · Cited by 25
Abou‐El‐Ardat, K., Monsieurs, P., Anastasov, N., Atkinson, M., Derradji, H., Meyer, T. D., Bekaert, S., Criekinge, W. V., & Baatout, S. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.10.006 · Cited by 24
Cho, S. D., Lei, P., Abdelrahim, M., Yoon, K., Liu, S., Guo, J., Papineni, S., Chintharlapalli, S. R., & Safe, S. H. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20378 · Cited by 24
Yang, C., Ma, J., Luo, Q., Neskey, D. M., Zhu, D., Liu, Y., Myers, J. N., Zhang, C., Zhang, Z., & Zhong, L. (2013) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12091 · Cited by 23
Aminothiol WR1065 induces differential gene expression in the presence of wild-type p53
Mann, K., & Hainaut, P. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208563 · Cited by 22
Na, K. R., Kim, Y. H., Chung, H. K., Yeo, M., Ham, Y. R., Jeong, J. Y., Kim, K. S., Lee, K. W., & Choi, D. E. (2017) · Internal Medicine Journal · doi:10.1111/imj.13614 · Cited by 23
DHODH inhibition modulates glucose metabolism and circulating GDF15, and improves metabolic balance
Zhang, J., Terán, G., Popa, M. L., Madapura, H. S., Ladds, M. J. G. W., Lianoudaki, D., Grünler, J., Arsenian‐Henriksson, M., McCormack, E., Rottenberg, M. E., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102494 · Cited by 25
Induction of MIC-1/growth differentiation factor-15 following bile duct injury
Koniaris, L. G. (2003) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-003-0037-5 · Cited by 23
Tesei, A., Rosetti, M., Ulivi, P., Fabbri, F., Medri, L., Vannini, I., Bolla, M., Amadori, D., & Zoli, W. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-52 · Cited by 23
O'Neill, R. S., Emmanuel, S., Williams, D. B., & Stoita, A. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i14.1660 · Cited by 22
Guo, J., Bian, Y., Wang, Y., Chen, L., Yu, A., & Sun, X. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3556 · Cited by 22
Isik, F. I., Thomson, S., Cueto, J. F., Spathos, J., Breit, S. N., Tsai, V. W.-W., Brown, D. A., & Finney, C. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1514518 · Cited by 25
Wong, J., Li, P.-X., & Klamut, H. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203020200 · Cited by 22
Self-citationTargeting the GDF15 Signalling for Obesity Treatment: Recent Advances and Emerging Challenges
Zhang, J., Sun, J., Li, J., & Xia, H. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70251 · Cited by 21
Metabolic Messenger: growth differentiation factor 15
Breit, S. N., & Tsai, V. W.-W. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01353-3 · Cited by 23
Thapa, D., Babu, D., Park, M., Kwak, M., Lee, Y. R., Kim, J., Kwon, T. K., & Kim, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.008 · Cited by 20
p53 and MDM2 are involved in the regulation of osteocalcin gene expression
Chen, H., Kolman, K., Lanciloti, N., Nerney, M. P., Hays, E., Robson, C., & Chandar, N. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.022 · Cited by 20
Su, Y., Vanderlaag, K. E., Ireland, C., Ortiz, J. M., Grage, H., Safe, S. H., & Frankel, A. E. (2007) · Breast Cancer Research · doi:10.1186/bcr1761 · Cited by 20
Metadata
- Authors
- Li, P.-X., Wong, J., Ayed, A., Ngo, D., Brade, A. M., Arrowsmith, C., Austin, R. C., & Klamut, H. J.
- Affiliations
- University Health Network (CA)
- McMaster University (CA)
- Corresponding author
- Klamut, Henry J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-06
- Volume
- 275
- Issue
- 26
- Pages
- 20127-20135
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2126527070
- Cited by
- 254
- References
- 88
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2022: 3 · 2021: 8 · 2020: 13 · 2019: 10 · 2018: 10 · 2017: 9 · 2016: 6 · 2015: 11 · 2014: 9 · 2013: 10 · 2012: 12
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Medical Research Council Canada
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- TGF-beta superfamily, p53, DNA damage, apoptosis, G1 cell cycle arrest, breast cancer, p53 binding sites, promoter induction, adenoviral overexpression, radiation-induced cell death, chemotherapeutic drug resistance
- MeSH terms
- Adenoviridae, Breast Neoplasms, Cell Cycle, Cell Division, Cell Survival, DNA Damage, Genetic Vectors, Growth Substances, Humans, Pregnancy Proteins, RNA, Messenger, Time Factors, Tissue Distribution, Tumor Cells, Cultured, Blotting, Northern, Transcriptional Activation, Up-Regulation, Genes, p53, Tumor Suppressor Protein p53, Apoptosis, Sequence Analysis, DNA, DNA, Complementary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review